Cite
APA Citation
Shi, Y., Fang, J., Shu, Y., Wang, D., Yu, H., Zhao, Y., Zhang, L., Zhu, B., Li, X., Chen, G., Shi, J., Zheng, R., Huang, J., Yang, S., Long, J., Gao, W., Greco, M., Hu, G., & Li, X. (n.d.). 476OA phase I study to evaluate safety and efficacy of BPI-7711 in EGFRm+/T790M+ advanced or recurrent NSCLC patients. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100098039198.0x000038